PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

PETACH TIKVA, Israel , May 20, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring